National Marrow Donor Program/Be The Match, Minneapolis, MN.
Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
JCO Clin Cancer Inform. 2022 Oct;6:e2200069. doi: 10.1200/CCI.22.00069.
Administrative claims data provide real-world service utilization of acute myeloid leukemia (AML) treatment, but lacks insight into treatment delays or barriers. The National Marrow Donor Program (NMDP)/Be The Match Search (Search) data contains information on donor search, but lacks information on treatment received if allogeneic hematopoietic cell transplant (HCT) is not performed. We hypothesized that linking these two data sets would create a rich resource to define factors associated with receiving HCT that could not be evaluated with either data set alone.
A subset of 2010-2016 Medicare administrative claims data was linked with Search data. A total of 5,351 patients with AML age 65-74 years (HCT = 607, no HCT = 4,744) were identified using Medicare. These patients were then linked to 93,800 records with a donor search between 2009 and 2016. Patient date of birth, sex, disease, ZIP code, transplant center/hospital, and diagnosis date were used for matching. Exploratory analysis was conducted to identify predictors associated with receiving HCT for patients with AML who received a search.
The data sets were successfully linked, showing high sensitivity and specificity. The final cohort included 5,085 patients with AML (HCT = 533, no HCT = 4,552). Of 97 patients who received HCT without a matched search, more than 85% received a related donor HCT. Of those not receiving HCT, 609 had a matched NMDP search and 3,943 did not have a matched NMDP search. Multivariate analysis showed time to search, age, diagnosis year, race/ethnicity, and neighborhood education status associated with receiving HCT.
Methods herein demonstrate the feasibility of linking Search and Medicare data. Similar methods may be applied to answer critical questions regarding barriers to HCT, thereby identifying areas to improve access to care.
行政索赔数据提供了急性髓细胞白血病(AML)治疗的实际服务利用情况,但缺乏对治疗延迟或障碍的了解。国家骨髓捐献者计划(NMDP)/Be The Match Search(Search)数据包含有关供者搜索的信息,但如果未进行异基因造血细胞移植(HCT),则缺乏有关所接受治疗的信息。我们假设将这两个数据集链接起来将创建一个丰富的资源,以确定与接受 HCT 相关的因素,而这些因素无法仅通过任何一个数据集来评估。
2010-2016 年医疗保险行政索赔数据的一个子集与 Search 数据相关联。使用医疗保险确定了年龄在 65-74 岁的 AML 患者共 5351 例(HCT=607 例,无 HCT=4744 例)。然后,将这些患者与 2009 年至 2016 年之间进行供者搜索的 93800 条记录相关联。患者的出生日期、性别、疾病、邮政编码、移植中心/医院和诊断日期用于匹配。进行了探索性分析,以确定与接受 AML 患者接受搜索相关的接受 HCT 的预测因素。
数据集成功链接,显示出高灵敏度和特异性。最终队列包括 5085 例 AML 患者(HCT=533 例,无 HCT=4552 例)。在 97 例未进行匹配搜索但接受 HCT 的患者中,超过 85%的患者接受了相关供者 HCT。在未接受 HCT 的患者中,有 609 例进行了匹配的 NMDP 搜索,而有 3943 例未进行匹配的 NMDP 搜索。多变量分析显示,搜索时间、年龄、诊断年份、种族/民族和社区教育状况与接受 HCT 相关。
本文中介绍的方法证明了将 Search 和医疗保险数据链接的可行性。类似的方法可以应用于回答有关 HCT 障碍的关键问题,从而确定改善获得护理的途径。